Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone®) increases antibody response, cellular immunity, and antigenically drifted protection
- 9 May 2009
- Vol. 27 (29) , 3811-3820
- https://doi.org/10.1016/j.vaccine.2009.04.054
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individualsJournal of Clinical Investigation, 2008
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007
- Safety and Immunogenicity of a Baculovirus-Expressed Hemagglutinin Influenza VaccineJAMA, 2007
- Distinct Contributions of Vaccine-Induced Immunoglobulin G1 (IgG1) and IgG2a Antibodies to Protective Immunity against InfluenzaClinical and Vaccine Immunology, 2006
- Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult VolunteersJournal of Virology, 2006
- Influenza and the challenge for immunologyNature Immunology, 2006
- Resistance to influenza A virus infection by antigen-conjugated CpG oligonucleotides, a novel antigen-specific immunomodulatorBiochemical and Biophysical Research Communications, 2005
- Resistance to and Recovery from Lethal Influenza Virus Infection in B Lymphocyte–deficient MiceThe Journal of Experimental Medicine, 1997
- Cytotoxic T-Cell Immunity to InfluenzaNew England Journal of Medicine, 1983
- The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B virusesEpidemiology and Infection, 1972